Protein 1 is linked to DNAdamage stress response. Embo J 2005, 24:3602?612. 34. Stenina OI, Shaneyfelt KM, DiCorleto PE: Thrombin induces the release of the Y-box protein dbpB from mRNA: a mechanism of transcriptional activation. Proc Natl Acad Sci U S A 2001, 98:7277?282. 35. Harendza S, Pollock AS, Mertens PR, Lovett DH: Tissue-specific enhancerpromoter interactions regulate high level constitutive expression of matrix metalloproteinase 2 by glomerular mesangial cells. J Biol Chem 1995, 270:18786?8796. 36.
Methyl 3-amino-2,4-dichloro-5-fluorobenzoate Mertens PR, Alfonso-Jaume MA, Steinmann K, Lovett DH: A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase a enhancer-dependent transcription. J Biol Chem 1998, 273:32957?2965. 37. Norman JT, Lindahl GE, Shakib K, En-Nia A, Yilmaz E, Mertens PR: The Y-box binding protein YB-1 suppresses collagen alpha 1(I) gene transcription via an evolutionarily conserved regulatory element in the proximal promoter. J Biol Chem 2001, 276:29880?9890. 38. Izumi H, Imamura T, Nagatani G, Ise T, Murakami T, Uramoto H, Torigoe T, Ishiguchi H, Yoshida Y, Nomoto M, et al: Y box-binding protein-1 binds preferentially to single-stranded nucleic acids and exhibits 35 exonuclease activity. Nucleic Acids Res 2001, 29:1200?207. 39. van Roeyen CR, Eitner F, Martinkus S, Thieltges SR, Ostendorf T, Bokemeyer
PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/18218841 D, Luscher B, Luscher-Firzlaff JM, Floege J, Mertens PR: Y-box protein 1 mediates PDGF-B effects in mesangioproliferative glomerular disease. J Am Soc Nephrol 2005, 16:2985?996. 40. Rauen T, Raffetseder U,
Boc-D-Lys-OH Frye BC, Djudjaj S, Muhlenberg PJ, Eitner F, Lendahl U, Bernhagen J, Dooley S, Mertens PR: YB-1 acts as a ligand for notch-3 receptors and modulates receptor activation. J Biol Chem 2009, 284:26928?6940. 41. Frye BC, Halfter S, Djudjaj S, Muehlenberg P, Weber S, Raffetseder U, En-Nia A, Knott H, Baron JM, Dooley S, et al: Y-box protein-1 is actively secreted42.43.44.45.46.47. 48.49.50.51.52.53.54.55.through a non-classical pathway and acts as an extracellular mitogen. EMBO reports 2009, 10:783?89. Hornbeck PV, Kornhauser JM, Tkachev S, Zhang B, Skrzypek E, Murray B, Latham V, Sullivan M: PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res 2012, 40:D261 270. Lutz M, Wempe F, Bahr I, Zopf D, von Melchner H: Proteasomal degradation of the multifunctional regulator YB-1 is mediated by an F-Box protein induced during programmed cell death. FEBS letters 2006, 580:3921?930. Cohen SB, Ma W, Valova VA, Algie M, Harfoot R, Woolley AG, Robinson PJ, Braithwaite AW: Genotoxic stress-induced nuclear localization of oncoprotein YB-1 in the absence of proteolytic processing. Oncogene 2010, 29:403?10. Woolley AG, Algie M, Samuel W, Harfoot R, Wiles A, Hung NA, Tan PH, Hains P, Valova VA, Huschtscha L, et al: Prognostic association of YB-1 expression in breast cancers: a matter of antibody. PLoS One 2011, 6:e20603. Ladomery M, Sommerville J: Binding of Y-box proteins to RNA: involvement of different protein domains. Nucleic Acids Res 1994, 22:5582?589. Sommerville J, Ladomery M: Masking of mRNA by Y-box proteins. FASEB J 1996, 10:435?43. Jurchott
PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/14445666 K, Kuban RJ, Krech T, Bluthgen N, Stein U, Walther W, Friese C, Kielbasa SM, Ungethum U, Lund P, et al: Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cells. PLoS Genet 2010, 6:e1001231. Lash.